Ledger.Open graph →

SEC Form D · filed October 3, 2023

Scinai Immunotherapeutics Ltd

Offering

$1.3M

Sold

$1.3M

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

JERUSALEM, L3

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (33)

Avner Rotman · JERUSALEM, L3Exec · Director Mark Germain · JERUSALEM, L3Director Morris Laster · JERUSALEM, L3Director Amir Reichman · JERUSALEM, L3Exec · Director Elad Mark · JERUSALEM, L3Exec Samuel Moed · JERUSALEM, L3Director Uri Ben Or · JERUSALEM, L3Exec Jay Green · JERUSALEM, L3Director Yael Margolin · JERUSALEM, L3Director Adi Raviv · JERUSALEM, L3Director Tamar Ben-Yedidia · JERUSALEM, L3Exec Jay Green · JERUSALEM, L3Director Elad Mark · JERUSALEM, L3Exec Yael Margolin · JERUSALEM, L3Director Adi Raviv · JERUSALEM, L3Director Morris Laster · JERUSALEM, L3Director Tamar Ben-Yedidia · JERUSALEM, L3Exec Amir Reichman · JERUSALEM, L3Exec · Director Samuel Moed · JERUSALEM, L3Director Uri Ben Or · JERUSALEM, L3Exec Avner Rotman · JERUSALEM, L3Exec · Director Mark Germain · JERUSALEM, L3Director Jake P. Donnelly · New York, NYExec Jody A. Markopoulos · Houston, TXExec John A. Stegeman · New York, NYDirector Mario Govic · Los Angeles, CAExec · Director Ugur Arslan · Orange Park, FLDirector Lidya Trading LLC · Orange Park, FLExec · Director Alexander Lamb · Manchester, MADirector Alexandra Ellis · Manchester, MAExec Natasha Lamb · Manchester, MADirector Scott B. Brown · Greenwood Village, CODirector Robin Bedford · Hamilton HM 11, BermudaDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗